Gene: LRRC34
Official Full Name: leucine rich repeat containing 34provided by HGNC
Gene Summary: Predicted to be involved in cell differentiation. Predicted to be located in cytoplasm and nucleolus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21925 | LRRC34 Knockout cell line (HEK293) | Human | LRRC34 | 1:3~1:6 | Negative | Online Inquiry |
LRRC34 Gene Knockout Cell Lines are genetically engineered cells specifically designed to lack the expression of the LRRC34 gene. This innovation leverages advanced gene-editing technologies, such as CRISPR-Cas9, to produce a precise knockout of the gene in various cell backgrounds, enabling researchers to investigate the gene’s function in biological processes, cellular signaling pathways, and disease models.
The primary mechanism of these knockout cell lines is the disruption of the LRRC34 gene, which is believed to be involved in key cellular functions, including the regulation of cell proliferation and differentiation. By creating a loss-of-function model, scientists can analyze the direct effects of LRRC34 absence, helping to uncover its role in physiological conditions and potential pathological states, such as cancer or developmental disorders. This functional assay not only aids in elucidating the gene's biological significance but also serves as a valuable tool for drug discovery and therapeutic development.
The scientific importance of LRRC34 Gene Knockout Cell Lines lies in their applicability in both basic research and translational studies. They facilitate high-throughput screening for compounds that may modulate the effects of LRRC34 deficiency, making them indispensable in the search for novel therapeutic strategies.
Compared to traditional gene knockdown methods, such as RNA interference, these knockout cell lines offer higher specificity and permanent gene inactivation. This permanence ensures consistent, reproducible results across experiments, reducing variability often seen with transient transfection methods.
For researchers and clinicians, the value of LRRC34 Gene Knockout Cell Lines is clear: they provide a reliable model for investigating gene function, validating molecular interactions, and identifying potential treatments for diseases linked to LRRC34 dysregulation. Our company, with extensive expertise in genetic engineering and cell line development, is committed to offering high-quality research products that pave the way for groundbreaking discoveries in molecular biology and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.